0001567619-20-014357.txt : 20200805 0001567619-20-014357.hdr.sgml : 20200805 20200805185607 ACCESSION NUMBER: 0001567619-20-014357 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200805 DATE AS OF CHANGE: 20200805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREY MICHAEL G CENTRAL INDEX KEY: 0001240122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 201079154 MAIL ADDRESS: STREET 1: C/O SGX PHARMACEUTICALS, INC. STREET 2: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2020-08-03 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001240122 GREY MICHAEL G C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2020-08-03 4 M 0 2500 26.49 A 45340 D Common Stock 2020-08-03 4 S 0 2500 120.35 D 42840 D Stock Option (Right to buy Common Stock) 26.49 2020-08-03 4 M 0 2500 0 D 2011-11-12 2021-05-11 Common Stock 2500 5000 D Trade made pursuant to a 10b5-1 plan executed on June 12, 2020. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2020-08-05